Publications by authors named "Michael H Cardone"

Claim this Profile
D
Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.
Andrew J Kinloch, Faiyaz Rahman, Bahriye Karakas, Muhammad Shahid, Bora Lim, Michael H Cardone

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.
Muhammad Hasan Bashari, Fengjuan Fan, Sonia Vallet, Martin Sattler, Melissa Arn, Michael H Cardone

Breast Cancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-apoptotic BCL-2 family proteins confer resistance to calicheamicin-based antibody-drug conjugate therapy of acute leukemia.
Colin D Godwin, Olivia M Bates, Sae Rin Jean, George S Laszlo, Eliotte E Garling, Michael H Cardone

Leuk Lymphoma· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma.
Mark A Schroeder, Mark A Fiala, Eric Huselton, Michael H Cardone, Savina Jaeger

Clin Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer.
Sonia Vallet, Fengjuan Fan, Stefano Malvestiti, Martin Pecherstorfer, Martin Sattler, Michael H Cardone

Breast Cancer Res Treat· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome.
Rupa Narayan, Jacqueline S Garcia, Mary-Elizabeth M Percival, Caroline Berube, Steve Coutre, Michael H Cardone

Leuk Lymphoma· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs.
Jo Ishizawa, Kensuke Kojima, Teresa McQueen, Vivian Ruvolo, Dhruv Chachad, Michael H Cardone

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell lines.
Brian Koss, Jeremy Ryan, Amit Budhraja, Katherine Szarama, Xue Yang, Michael H Cardone

Oncotarget· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.
Muhammad Hasan Bashari, Fengjuan Fan, Sonia Vallet, Martin Sattler, Melissa Arn, Michael H Cardone

Breast Cancer Res· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL).
Kami Maddocks, Lai Wei, Darlene Rozewski, Yao Jiang, Yuan Zhao, Michael H Cardone

Am J Hematol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mcl-1 dependence predicts response to vorinostat and gemtuzumab ozogamicin in acute myeloid leukemia.
William E Pierceall, Ryan J Lena, Bruno C Medeiros, Noel Blake, Camille Doykan, Michael H Cardone

Leuk Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response.
Timothy G Whitsett, Ian T Mathews, Michael H Cardone, Ryan J Lena, William E Pierceall

Mol Cancer Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BH3 profiling discriminates response to cytarabine-based treatment of acute myelogenous leukemia.
William E Pierceall, Steven M Kornblau, Nicole E Carlson, Xuelin Huang, Noel Blake, Michael H Cardone

Mol Cancer Ther· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyquinoline-derived compounds and analoguing of selective Mcl-1 inhibitors using a functional biomarker.
David J Richard, Ryan Lena, Thomas Bannister, Noel Blake, William E Pierceall, Michael H Cardone

Bioorg Med Chem· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions.
Fei Hua, Melanie G Cornejo, Michael H Cardone, Cynthia L Stokes, Douglas A Lauffenburger

J Immunol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis